Cancer Research UK is providing nearly £100,000 in funding to scientists at the University of Edinburgh, led by Dr. Marta Canel, in their quest to develop a blood test capable of detecting pancreatic cancer in its early stages. The initiative aims to revolutionize the diagnosis of this aggressive cancer, which is typically identified at an advanced stage when treatment options are limited.
Pancreatic cancer is a significant cause of cancer-related deaths in the UK, primarily due to late diagnosis. The university team’s research will concentrate on specific genes – KRAS, SMAD4, and CDKN2A – which when altered, lead to uncontrolled division and growth of cancer cells.
Stay connected to UKNIP via Google News
ENJOYED THIS STORY? Choose UKNIP as a 'Preferred Source' on Google News for quick access to the news you value.
